Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting the epidermal growth factor receptor: an important incremental step in the battle against colorectal cancer.

× No keyword cloud information.

8 in total

Review 1. EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors: Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal: Curr Drug Targets Date: 2010-06 Impact factor: 3.465

Review 2. Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors: Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal: Langenbecks Arch Surg Date: 2005-12-01 Impact factor: 3.445

Review 3. Clinical experience with monoclonal antibodies to epidermal growth factor receptor.

Authors: Emiliano Calvo; Eric K Rowinsky
Journal: Curr Oncol Rep Date: 2005-03 Impact factor: 5.075

4. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?

Authors: S Leibl; F Moinfar
Journal: J Clin Pathol Date: 2005-07 Impact factor: 3.411

5. Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.

Authors: Ramaswamy Bhuvaneswari; Yik Yuen Gan; Khee Chee Soo; Malini Olivo
Journal: Mol Cancer Date: 2009-11-02 Impact factor: 27.401

6. Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab.

Authors: Mario Scartozzi; Riccardo Giampieri; Elena Maccaroni; Alessandra Mandolesi; Simona Biagetti; Simona Alfonsi; Lucio Giustini; Cristian Loretelli; Luca Faloppi; Alessandro Bittoni; Maristella Bianconi; Michela Del Prete; Italo Bearzi; Stefano Cascinu
Journal: J Transl Med Date: 2012-04-10 Impact factor: 5.531

7. Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.

Authors: M Scartozzi; I Bearzi; R Berardi; A Mandolesi; C Pierantoni; S Cascinu
Journal: Br J Cancer Date: 2007-06-19 Impact factor: 7.640

8. A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.

Authors: S Cascinu; R Berardi; S Salvagni; G D Beretta; V Catalano; F Pucci; A Sobrero; P Tagliaferri; R Labianca; M Scartozzi; F Crocicchio; E Mari; A Ardizzoni
Journal: Br J Cancer Date: 2007-12-04 Impact factor: 7.640

8 in total